Latest news with #Bowel
Gulf Today
04-07-2025
- Health
- Gulf Today
Burjeel Hospital Abu Dhabi earns ACHSI accreditation for excellence in Gastroenterology and Diagnostics
The accreditation process is based on rigorous standards of quality, patient safety, clinical excellence, and continuous improvement. In recognition of its leadership in providing advanced, patient-centered care, Burjeel Hospital Abu Dhabi has received a certification from the Australian Council on Healthcare Standards International (ACHSI) for its Gastroenterology & Diagnostic Services. This prestigious certification highlights the hospital's strong commitment to quality, clinical excellence, and continuous improvement. ACHSI is a globally recognized, not-for-profit organization known for promoting global best practices in healthcare delivery. Its accreditation process is based on rigorous standards of quality, patient safety, clinical excellence, and continuous improvement. Being recognized by ACHSI places Burjeel Hospital Abu Dhabi among an elite group of global institutions that meet the highest standards in healthcare quality. Specialized Care for GI Health Burjeel Hospital Abu Dhabi brings together the expertise of a highly skilled, multidisciplinary team, including gastrointestinal surgeons, radiologists, pathologists, oncologists, GI nurses, and technicians, adhering to international guidelines and standardized care protocols to ensure clinical excellence. Specialized services are delivered with precision, compassion, and efficiency across the entire spectrum of gastrointestinal, pancreatobiliary, and liver diseases. The hospital is known for its specialized services including advanced endoscopy services that facilitate early detection and treatment of gastrointestinal cancers, including pancreatic cancer screening for high-risk populations, and palliative interventions for advanced malignancies. The hospital's capabilities extend to highly specialized areas such as pancreatobiliary endoscopy, with expertise in ERCP, cholangioscopy, endoscopic ultrasound, and minimally invasive procedures for drainage, ablation, etc. Its Third Space Endoscopy services include complex interventions like endoscopic submucosal dissection, peroral endoscopic myotomy, submucosal tunneling endoscopic resection, and full-thickness resection. The hospital's Inflammatory Bowel Disease (IBD) program is comprehensive, offering personalized treatment plans backed by all approved biologic therapies and advanced monitoring. Liver disease management includes care for MASLD, autoimmune and viral hepatitis, and cirrhosis, with a strong focus on liver transplant readiness and follow-up. Services in motility and neurogastroenterology are also highly advanced, including pH monitoring, high-resolution manometry, and endoscopic treatment of GERD. A dedicated endobariatrics unit offers minimally invasive interventions such as endoscopic sleeve gastroplasty and transoral outlet reduction. Burjeel's For Women By Women program further ensures privacy, dignity, and comfort by offering specialized GI care from an all-female team. 'This recognition by ACHSI reflects our deep-rooted commitment to clinical excellence, innovation, and compassionate care. It strengthens our position on the global healthcare stage and reinforces our appeal to international patients and partners seeking world-class, collaborative care,' said Mr. Waleed Tawfik, Chief Operations Officer, Burjeel Hospital Abu Dhabi. Advanced Diagnostic Technology The hospital's commitment to excellence is reinforced by its investment in advanced diagnostic technology. It uses AI-enhanced endoscopy systems to improve real-time detection of early-stage cancers, boosting procedural accuracy and efficiency. High-definition and narrow-band imaging provide enhanced visualization and lesion characterization, while structured digital endoscopy reporting systems ensure standardized documentation and seamless clinical coordination. The gastrointestinal motility lab offers a full spectrum of diagnostics, including esophageal and anorectal manometry, wireless pH monitoring, non-invasive breath tests, and biofeedback therapy. With this achievement, Burjeel Hospital Abu Dhabi continues to set new benchmarks for specialty care in the region, delivering advanced, evidence-based medicine in a compassionate, patient-first environment.
The Advertiser
14-06-2025
- Health
- The Advertiser
Pharmacists push for new bowel screening approach
As Australia falls short of its national cancer bowel screening targets, pharmacists are calling for a revamped approach. The latest National Bowel Cancer Program monitoring report found of the 6.28 million Australians invited to take part, nearly six in 10 aged between 50 and 74 did not return their free bowel cancer screening test. Despite a target participation rate of 55 per cent, only 41.7 per cent of people have taken up the opportunity to take a free bowel cancer screening test. The lack of take up is surprising, given it's Australia's deadliest cancer. Pharmacy Guild of Australia national president Trent Twomey says the current approach of sending tests to eligible Australians through the mail "isn't working" and it's time to try something new. "Australia needs to make the most of all its health professionals to increase early screening," he said. "On average people visit a community pharmacy every three weeks. Community pharmacies are open into the evenings and weekends, making them the most accessible frontline health service." Pharmacist and Bowel Cancer ambassador Jane Hoffman lost her husband to the deadly disease at 42. "For too many, like my beloved husband Marty, the diagnosis is too late," she said. "Young dads like Marty might test earlier if prompted by a community pharmacist." Bowel cancer is Australia's second deadliest cancer, but if detected early almost 90 per cent of cases can be treated successfully. Screening aims to detect early signs in healthy individuals. Those without symptoms of bowel cancer should consider being screened, with a test every two years recommended for those aged 45-74. These tests are currently posted to patients but a large number are unreturned. Tests for those aged 40-44 and 75-85 are available to purchase privately at local pharmacies. As Australia falls short of its national cancer bowel screening targets, pharmacists are calling for a revamped approach. The latest National Bowel Cancer Program monitoring report found of the 6.28 million Australians invited to take part, nearly six in 10 aged between 50 and 74 did not return their free bowel cancer screening test. Despite a target participation rate of 55 per cent, only 41.7 per cent of people have taken up the opportunity to take a free bowel cancer screening test. The lack of take up is surprising, given it's Australia's deadliest cancer. Pharmacy Guild of Australia national president Trent Twomey says the current approach of sending tests to eligible Australians through the mail "isn't working" and it's time to try something new. "Australia needs to make the most of all its health professionals to increase early screening," he said. "On average people visit a community pharmacy every three weeks. Community pharmacies are open into the evenings and weekends, making them the most accessible frontline health service." Pharmacist and Bowel Cancer ambassador Jane Hoffman lost her husband to the deadly disease at 42. "For too many, like my beloved husband Marty, the diagnosis is too late," she said. "Young dads like Marty might test earlier if prompted by a community pharmacist." Bowel cancer is Australia's second deadliest cancer, but if detected early almost 90 per cent of cases can be treated successfully. Screening aims to detect early signs in healthy individuals. Those without symptoms of bowel cancer should consider being screened, with a test every two years recommended for those aged 45-74. These tests are currently posted to patients but a large number are unreturned. Tests for those aged 40-44 and 75-85 are available to purchase privately at local pharmacies. As Australia falls short of its national cancer bowel screening targets, pharmacists are calling for a revamped approach. The latest National Bowel Cancer Program monitoring report found of the 6.28 million Australians invited to take part, nearly six in 10 aged between 50 and 74 did not return their free bowel cancer screening test. Despite a target participation rate of 55 per cent, only 41.7 per cent of people have taken up the opportunity to take a free bowel cancer screening test. The lack of take up is surprising, given it's Australia's deadliest cancer. Pharmacy Guild of Australia national president Trent Twomey says the current approach of sending tests to eligible Australians through the mail "isn't working" and it's time to try something new. "Australia needs to make the most of all its health professionals to increase early screening," he said. "On average people visit a community pharmacy every three weeks. Community pharmacies are open into the evenings and weekends, making them the most accessible frontline health service." Pharmacist and Bowel Cancer ambassador Jane Hoffman lost her husband to the deadly disease at 42. "For too many, like my beloved husband Marty, the diagnosis is too late," she said. "Young dads like Marty might test earlier if prompted by a community pharmacist." Bowel cancer is Australia's second deadliest cancer, but if detected early almost 90 per cent of cases can be treated successfully. Screening aims to detect early signs in healthy individuals. Those without symptoms of bowel cancer should consider being screened, with a test every two years recommended for those aged 45-74. These tests are currently posted to patients but a large number are unreturned. Tests for those aged 40-44 and 75-85 are available to purchase privately at local pharmacies. As Australia falls short of its national cancer bowel screening targets, pharmacists are calling for a revamped approach. The latest National Bowel Cancer Program monitoring report found of the 6.28 million Australians invited to take part, nearly six in 10 aged between 50 and 74 did not return their free bowel cancer screening test. Despite a target participation rate of 55 per cent, only 41.7 per cent of people have taken up the opportunity to take a free bowel cancer screening test. The lack of take up is surprising, given it's Australia's deadliest cancer. Pharmacy Guild of Australia national president Trent Twomey says the current approach of sending tests to eligible Australians through the mail "isn't working" and it's time to try something new. "Australia needs to make the most of all its health professionals to increase early screening," he said. "On average people visit a community pharmacy every three weeks. Community pharmacies are open into the evenings and weekends, making them the most accessible frontline health service." Pharmacist and Bowel Cancer ambassador Jane Hoffman lost her husband to the deadly disease at 42. "For too many, like my beloved husband Marty, the diagnosis is too late," she said. "Young dads like Marty might test earlier if prompted by a community pharmacist." Bowel cancer is Australia's second deadliest cancer, but if detected early almost 90 per cent of cases can be treated successfully. Screening aims to detect early signs in healthy individuals. Those without symptoms of bowel cancer should consider being screened, with a test every two years recommended for those aged 45-74. These tests are currently posted to patients but a large number are unreturned. Tests for those aged 40-44 and 75-85 are available to purchase privately at local pharmacies.
West Australian
14-06-2025
- Health
- West Australian
Pharmacists push for new bowel screening approach
As Australia falls short of its national cancer bowel screening targets, pharmacists are calling for a revamped approach. The latest National Bowel Cancer Program monitoring report found of the 6.28 million Australians invited to take part, nearly six in 10 aged between 50 and 74 did not return their free bowel cancer screening test. Despite a target participation rate of 55 per cent, only 41.7 per cent of people have taken up the opportunity to take a free bowel cancer screening test. The lack of take up is surprising, given it's Australia's deadliest cancer. Pharmacy Guild of Australia national president Trent Twomey says the current approach of sending tests to eligible Australians through the mail "isn't working" and it's time to try something new. "Australia needs to make the most of all its health professionals to increase early screening," he said. "On average people visit a community pharmacy every three weeks. Community pharmacies are open into the evenings and weekends, making them the most accessible frontline health service." Pharmacist and Bowel Cancer ambassador Jane Hoffman lost her husband to the deadly disease at 42. "For too many, like my beloved husband Marty, the diagnosis is too late," she said. "Young dads like Marty might test earlier if prompted by a community pharmacist." Bowel cancer is Australia's second deadliest cancer, but if detected early almost 90 per cent of cases can be treated successfully. Screening aims to detect early signs in healthy individuals. Those without symptoms of bowel cancer should consider being screened, with a test every two years recommended for those aged 45-74. These tests are currently posted to patients but a large number are unreturned. Tests for those aged 40-44 and 75-85 are available to purchase privately at local pharmacies.
Perth Now
14-06-2025
- Health
- Perth Now
Pharmacists push for new bowel screening approach
As Australia falls short of its national cancer bowel screening targets, pharmacists are calling for a revamped approach. The latest National Bowel Cancer Program monitoring report found of the 6.28 million Australians invited to take part, nearly six in 10 aged between 50 and 74 did not return their free bowel cancer screening test. Despite a target participation rate of 55 per cent, only 41.7 per cent of people have taken up the opportunity to take a free bowel cancer screening test. The lack of take up is surprising, given it's Australia's deadliest cancer. Pharmacy Guild of Australia national president Trent Twomey says the current approach of sending tests to eligible Australians through the mail "isn't working" and it's time to try something new. "Australia needs to make the most of all its health professionals to increase early screening," he said. "On average people visit a community pharmacy every three weeks. Community pharmacies are open into the evenings and weekends, making them the most accessible frontline health service." Pharmacist and Bowel Cancer ambassador Jane Hoffman lost her husband to the deadly disease at 42. "For too many, like my beloved husband Marty, the diagnosis is too late," she said. "Young dads like Marty might test earlier if prompted by a community pharmacist." Bowel cancer is Australia's second deadliest cancer, but if detected early almost 90 per cent of cases can be treated successfully. Screening aims to detect early signs in healthy individuals. Those without symptoms of bowel cancer should consider being screened, with a test every two years recommended for those aged 45-74. These tests are currently posted to patients but a large number are unreturned. Tests for those aged 40-44 and 75-85 are available to purchase privately at local pharmacies.
Time of India
29-05-2025
- Health
- Time of India
What is short bowel syndrome? How serious is it?
When 4-year-old S.G.V. appeared at a recent press conference in Los Angeles, she seemed like any other preschooler—quietly coloring and playing cards. But the backpack strapped to her shoulders told a different story. Inside it was the equipment delivering life-sustaining nutrition directly into her bloodstream, a treatment known as Total Parenteral Nutrition (TPN). S.G.V. lives with short bowel syndrome (SBS), a rare but serious condition that makes her unable to absorb nutrients from food. Without the nightly intravenous nutrition she receives in the U.S., doctors say she would not survive more than a few days. Her case recently drew national attention because of a change to her family's immigration status, which threatens to interrupt the care that keeps her alive. But beyond the legal battle is a far more urgent medical issue: What exactly is short bowel syndrome, and why is it so dangerous? What is Short Bowel Syndrome? According to the Mayo Clinic, short bowel syndrome is a condition in which the body cannot absorb enough nutrients from the food you eat because part of the small intestine is missing or damaged. The small intestine is where most nutrients are absorbed during digestion. When a large portion of it is removed or doesn't function properly, the body can't get enough protein, fat, carbohydrates, vitamins, or minerals to survive. SBS can happen in two ways: A person is born with part of the intestine missing or damaged. A person has to have large sections of the small intestine surgically removed due to conditions like Crohn's disease, cancer, trauma, or blood clots in the intestinal arteries. How does it affect the body? The Cleveland Clinic explains that while the body has some ability to adapt to small intestinal changes, losing too much—especially the jejunum or ileum—makes it very difficult to absorb nutrients. In many cases, the ileum (the final portion of the small intestine) can take over some of the roles of the missing segments. But when too much of the intestine is gone, even that adaptation isn't enough. In infants like S.G.V., this can lead to severe malnutrition, dehydration, and growth failure. Symptoms in children Signs of short bowel syndrome in children include: Chronic diarrhea or loose, watery stool Bloating and excessive gas Fatigue Foul-smelling stool Poor weight gain or failure to grow These symptoms come from the body's inability to digest and absorb essential nutrients, fluids, and electrolytes. How is Short Bowel Syndrome treated? Dietary Changes Children with milder forms of SBS may benefit from frequent small meals, high-calorie foods, and supplements of vitamins and minerals. They may need to avoid certain foods that are hard to digest, such as those high in fat, sugar, or fiber. However, in more severe cases—like S.G.V.'s—diet alone is not enough. Total Parenteral Nutrition (TPN) TPN is a method of delivering nutrients directly into the bloodstream through a special IV catheter, bypassing the digestive system entirely. The fluid contains carbohydrates, protein, fats, electrolytes, and vitamins. This is the primary treatment for children with severe SBS. It is often given overnight for 12–16 hours to allow children to be mobile during the day. As in S.G.V.'s case, some children use portable TPN backpacks, which allow them to attend school or go outside while still receiving nutrition. 'If her treatment is interrupted, she will die within days,' said Gina Amato, the family's attorney, to NBC News. However, long-term use of total parenteral nutrition (TPN) can lead to several serious complications. These include bacterial infections, issues with the intravenous catheter, and blood clots. Over time, TPN may also reduce the body's ability to absorb calcium into the bones, increasing the risk of bone weakening. It can contribute to gallbladder disease, kidney damage, and liver problems. In severe cases, these complications may progress to kidney or liver failure. Enteral feeding (Tube Feeding) Some children also need a feeding tube inserted into the stomach or intestines to get liquid nutrition. This may be used in combination with TPN to encourage the intestines to function as much as possible. Complications of Short Bowel Syndrome Because the body can't absorb nutrients the usual way, SBS comes with serious health risks: Malnutrition and vitamin deficiencies Electrolyte imbalance (sodium, potassium, magnesium) Dehydration Gallstones Kidney stones Liver disease from long-term TPN Infections related to central IV lines In infants, complications like cholestasis (bile backup in the liver) and intestinal failure-associated liver disease are particularly dangerous. One step to a healthier you—join Times Health+ Yoga and feel the change
